PPARγ Activation in DSS-Induced Inflammatory Bowel Disease
2026-09-08
The reference study links PPARγ activation with macrophage-state balance and reduced DSS-induced intestinal inflammation through coordinated changes in STAT-1 and STAT-6 signaling. Its combined RAW264.7-cell and mouse-model design provides a mechanistic framework for evaluating pioglitazone in inflammatory bowel disease research while underscoring the limits of direct clinical translation.
PFHxS Hepatotoxicity via PPAR Signaling in Zebrafish
2026-09-07
This study integrates transcriptomics, liver pathology, biochemical assays, targeted gene analysis, pharmacological antagonism, and morpholino knockdown to show that environmentally relevant PFHxS exposure disrupts liver development and function in larval zebrafish. Its main contribution is mechanistic triangulation: the findings connect hepatic steatosis and injury with altered PPAR signaling while illustrating how early-life fish models can support environmental toxicology and metabolic research.
Birinapant (TL32711) for Reliable Apoptosis Assays
2026-09-05
This scenario-driven guide explains how Birinapant (TL32711), SKU A4219, can support reproducible apoptosis, viability, and cytotoxicity workflows by linking IAP antagonism to practical assay controls. It also addresses stock preparation, endpoint interpretation, MDM1-related chemoradiotherapy resistance, and evidence-based product selection.
Salvianolic acid B in Pulmonary Fibrosis Research
2026-09-05
Salvianolic acid B, also known as Dan Shen Suan B, gives fibrosis researchers a practical way to connect LH2 expression with collagen cross-linking, matrix stiffness, and tissue remodeling. This workflow combines concentration screening, orthogonal molecular readouts, and troubleshooting guidance for cell, tissue, and extracellular matrix studies.
EGCG Nanoparticles Enhance FLASH-RT Antitumor Effects
2026-09-04
Xu et al. report that functionalized self-assembled epigallocatechin gallate nanoparticles, termed BENPs, can sensitize tumors to FLASH radiotherapy by increasing oxidative DNA damage and strengthening antitumor immune responses. The study provides a preclinical framework for linking radiosensitization, tumor-cell death, and immune remodeling while highlighting the need for careful dosimetry and mechanistic validation.
Thiazovivin: Practical ROCK Inhibitor Workflow
2026-09-04
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and recovery of human embryonic stem cells after trypsinization. This guide covers handling, controls, and troubleshooting, while noting that model-specific dosing, timing, and performance should be established experimentally rather than inferred from the product dossier.
Septic Shock, Renal Blood Flow, and K+ Channels
2026-09-03
This study separates basal renal perfusion from agonist-evoked vascular responses in septic rats and shows that blocking distinct potassium-channel populations can worsen renal hypoperfusion during pressor treatment. Its integrated ex vivo and in vivo design highlights why renal vascular responses should not be inferred from systemic blood pressure alone.
Tubastatin A: HDAC6, Cell Death and Assay Design
2026-09-03
Tubastatin A is a selective HDAC6 inhibitor that connects microtubule regulation with inflammatory and regulated cell-death phenotypes. This article interprets recent porcine cardiac-arrest data as a framework for designing more discriminating translational assays.
ML133 HCl: Selective Kir2.1 Channel Inhibitor
2026-09-02
ML133 HCl is a selective potassium channel inhibitor for studying Kir2.1 potassium channels and potassium ion transport. Its pH-dependent potency and published effects in pulmonary artery smooth muscle cells support controlled mechanistic research, not direct clinical use.
Phosbind Acrylamide for Phosphorylation Mapping
2026-09-02
Phosbind Acrylamide enables antibody-free protein phosphorylation analysis through phosphate-dependent mobility shifts in SDS-PAGE. This article translates findings from a fungal ubiquitination–autophagy study into practical decisions for selecting, controlling, and interpreting phosphorylation assays.
HBTU in Peptide Synthesis: Mechanism and Use
2026-09-01
HBTU is a peptide coupling reagent that activates carboxylic acids for efficient peptide bond formation, especially in solid phase peptide synthesis. Its mild activation profile, solvent compatibility, and racemization-resistant behavior support rapid research-scale peptide assembly, but HBTU itself has no established in vivo or clinical evidence.
EdU Flow Cytometry Assay Kits (Cy5) Guide
2026-09-01
EdU Flow Cytometry Assay Kits (Cy5) provide an endpoint flow cytometry method for measuring DNA synthesis during S phase through Cy5-based click chemistry detection. They are appropriate for fixed-cell proliferation, genotoxicity, and pharmacodynamic workflows, but should not be treated as validated live-cell or in vivo imaging reagents without additional adaptation.
Spatially Concentrated ABEs Correct PLP1 Mutations
2026-08-31
This 2026 Nucleic Acids Research study introduces spatially concentrated adenine base editors that improve editing in oligodendrocytes by locally enriching the TadA* deaminase near genomic targets. An AAV-compatible cABE-2.0 variant corrected the PLP1 A243V mutation, reduced transcriptome-wide RNA off-target effects, and improved myelination-related phenotypes in disease-relevant models.
RNA Pol II Inhibition and Active Cell Death
2026-08-30
Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic response rather than passive loss of transcription, mRNA, and protein. Their identification of the Pol II degradation-dependent apoptotic response, or PDAR, reframes how transcription-targeting drugs and their mitochondrial death signals should be interpreted.
AMPK, ULK1, and Autophagy Under Energy Stress
2026-08-29
The reference study revises the prevailing view that AMPK uniformly promotes autophagy during glucose deprivation. Its experiments show that AMPK suppresses ULK1-dependent autophagy initiation during acute energy stress while preserving the autophagy machinery for recovery after stress subsides, providing a more nuanced framework for interpreting AMPK-targeted interventions.
461 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page